• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.垂体学会德尔菲调查:经蝶窦手术治疗垂体腺瘤患者内分泌管理的国际视角。
Pituitary. 2022 Feb;25(1):64-73. doi: 10.1007/s11102-021-01170-3. Epub 2021 Jul 20.
2
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection.垂体学会专家德尔菲共识:经鼻蝶窦垂体腺瘤切除术的手术流程。
Pituitary. 2021 Dec;24(6):839-853. doi: 10.1007/s11102-021-01162-3. Epub 2021 Jul 6.
3
Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.儿童垂体腺瘤的经蝶窦手术:一项多中心回顾性研究。
Childs Nerv Syst. 2019 Nov;35(11):2119-2126. doi: 10.1007/s00381-019-04179-z. Epub 2019 May 11.
4
Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.影响经蝶窦显微手术治疗垂体腺瘤效果的因素:184 例患者研究。
Hormones (Athens). 2013 Apr-Jun;12(2):254-64. doi: 10.14310/horm.2002.1409.
5
Microsurgical therapy of pituitary adenomas.垂体腺瘤的显微外科治疗。
Endocrine. 2018 Jan;59(1):72-81. doi: 10.1007/s12020-017-1458-3. Epub 2017 Oct 24.
6
Use of high-field intraoperative magnetic resonance imaging during endoscopic transsphenoidal surgery for functioning pituitary microadenomas and small adenomas located in the intrasellar region.在经蝶窦内镜手术中使用高场术中磁共振成像治疗位于鞍内区域的功能性垂体微腺瘤和小腺瘤。
Neurol Med Chir (Tokyo). 2013;53(7):501-10. doi: 10.2176/nmc.53.501.
7
Pituitary adenomas in older adults (≥ 65 years): 90-day outcomes and readmissions: a 10-year endoscopic endonasal surgical experience.老年(≥65 岁)垂体腺瘤:90 天结局和再入院:10 年内镜经鼻手术经验。
Pituitary. 2021 Feb;24(1):14-26. doi: 10.1007/s11102-020-01081-9. Epub 2020 Sep 16.
8
Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.中国某单一中心的 1 型多发性内分泌肿瘤患者的垂体腺瘤:单中心经验。
Pituitary. 2019 Apr;22(2):113-123. doi: 10.1007/s11102-019-00939-x.
9
Radiation therapy in the multimodal treatment approach of pituitary adenoma.垂体腺瘤多模式治疗方法中的放射治疗。
Strahlenther Onkol. 2002 Apr;178(4):173-86. doi: 10.1007/s00066-002-0826-x.
10
Perioperative management of patients undergoing transsphenoidal pituitary surgery.经蝶窦垂体手术患者的围手术期管理
Anesth Analg. 2005 Oct;101(4):1170-1181. doi: 10.1213/01.ane.0000166976.61650.ae.

引用本文的文献

1
Isolated syndrome of inappropriate antidiuresis (SIAD) after Transphenoidal surgery of a non-functioning pituitary adenoma: clinical case report.无功能垂体腺瘤经蝶窦手术后孤立性抗利尿激素分泌不当综合征(SIAD):临床病例报告
Oxf Med Case Reports. 2025 Aug 25;2025(8):omaf152. doi: 10.1093/omcr/omaf152. eCollection 2025 Aug.
2
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.垂体偶发瘤:一项垂体协会国际共识指南声明
Nat Rev Endocrinol. 2025 Jun 24. doi: 10.1038/s41574-025-01134-8.
3
Evidence-based management strategies for endocrine complications after pituitary adenoma surgery.垂体腺瘤手术后内分泌并发症的循证管理策略
Ibrain. 2024 May 23;11(2):245-258. doi: 10.1002/ibra.12156. eCollection 2025 Summer.
4
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.生长激素缺乏症诊断的共识与争议:生长激素研究学会的德尔菲调查
Pituitary. 2025 May 7;28(3):57. doi: 10.1007/s11102-025-01526-z.
5
Perioperative glucocorticoid supplementation in pituitary surgery.垂体手术围手术期糖皮质激素补充治疗
Cochrane Database Syst Rev. 2025 Mar 21;3(3):CD015909. doi: 10.1002/14651858.CD015909.
6
Pituitary and COVID-19 vaccination: a systematic review.垂体与新冠疫苗接种:一项系统综述
Pituitary. 2024 Dec;27(6):970-985. doi: 10.1007/s11102-024-01402-2. Epub 2024 May 18.
7
Patient and caregiver perspectives of fluid discharge protocols following pituitary surgery.垂体手术后液体排出方案的患者及照料者观点
J Clin Transl Endocrinol. 2024 Mar 16;35:100336. doi: 10.1016/j.jcte.2024.100336. eCollection 2024 Mar.
8
Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine Perspective.人类库欣综合征(皮质醇增多症)诊断与管理中的陷阱:检验医学视角综述
Diagnostics (Basel). 2023 Apr 14;13(8):1415. doi: 10.3390/diagnostics13081415.
9
Treatment of Prolactinoma.催乳素瘤的治疗。
Medicina (Kaunas). 2022 Aug 13;58(8):1095. doi: 10.3390/medicina58081095.
10
Diagnosis and Management of Central Diabetes Insipidus in Adults.成人中枢性尿崩症的诊断与治疗。
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715. doi: 10.1210/clinem/dgac381.

本文引用的文献

1
Dumbbell-shaped pituitary adenomas: prognostic factors for prediction of tumor nondescent of the supradiaphragmal component from a multicenter series.哑铃形垂体腺瘤:多中心系列研究中预测膈上部分肿瘤未下降的预后因素
J Neurosurg. 2021 Dec 24;137(3):609-617. doi: 10.3171/2021.9.JNS211689. Print 2022 Sep 1.
2
A Pituitary Society update to acromegaly management guidelines.垂体学会关于肢端肥大症管理指南的更新。
Pituitary. 2021 Feb;24(1):1-13. doi: 10.1007/s11102-020-01091-7. Epub 2020 Oct 20.
3
Pituitary-Tumor Endocrinopathies.垂体肿瘤内分泌病
N Engl J Med. 2020 Mar 5;382(10):937-950. doi: 10.1056/NEJMra1810772.
4
Biochemical diagnosis in prolactinomas: some caveats.催乳素瘤的生化诊断:一些注意事项。
Pituitary. 2020 Feb;23(1):9-15. doi: 10.1007/s11102-019-01024-z.
5
Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations.常见内分泌实验室检查的解读:技术陷阱、其机制及实际考量
Clin Diabetes Endocrinol. 2019 Jul 24;5:12. doi: 10.1186/s40842-019-0086-7. eCollection 2019.
6
Pituitary Macroprolactinoma with Mildly Elevated Serum Prolactin: Hook Effect.血清催乳素轻度升高的垂体大泌乳素瘤:钩状效应。
Adv J Emerg Med. 2018 Apr 28;2(4):e49. doi: 10.22114/AJEM.v0i0.84. eCollection 2018 Fall.
7
Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy.性激素与静脉血栓栓塞——从避孕到激素替代疗法
Vasa. 2018 Oct;47(6):441-450. doi: 10.1024/0301-1526/a000726. Epub 2018 Jul 16.
8
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.库欣综合征的术前治疗:使用频率及其对术后评估的影响:ERCUSYN 数据。
Eur J Endocrinol. 2018 Apr;178(4):399-409. doi: 10.1530/EJE-17-0997. Epub 2018 Feb 12.
9
Silent somatotroph pituitary adenomas: an update.无功能性垂体腺瘤:更新。
Pituitary. 2018 Apr;21(2):194-202. doi: 10.1007/s11102-017-0858-y.
10
Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.促肾上腺皮质激素细胞腺瘤无功能性复发的预测因素:一项大型回顾性单中心研究和系统文献复习。
Pituitary. 2018 Feb;21(1):32-40. doi: 10.1007/s11102-017-0844-4.

垂体学会德尔菲调查:经蝶窦手术治疗垂体腺瘤患者内分泌管理的国际视角。

Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.

机构信息

Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

Pituitary. 2022 Feb;25(1):64-73. doi: 10.1007/s11102-021-01170-3. Epub 2021 Jul 20.

DOI:10.1007/s11102-021-01170-3
PMID:34283370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8294287/
Abstract

PURPOSE

In adults and children, transsphenoidal surgery (TSS) represents the cornerstone of management for most large or functioning sellar lesions with the exception of prolactinomas. Endocrine evaluation and management are an essential part of perioperative care. However, the details of endocrine assessment and care are not universally agreed upon.

METHODS

To build consensus on the endocrine evaluation and management of adults undergoing TSS, a Delphi process was used. Thirty-five statements were developed by the Pituitary Society's Education Committee. Fifty-five pituitary endocrinologists, all members of the Pituitary Society, were invited to participate in two Delphi rounds and rate their extent of agreement with statements pertaining to perioperative endocrine evaluation and management, using a Likert-type scale. Anonymized data on the proportion of panelists' agreeing with each item were summarized. A list of items that achieved consensus, based on predefined criteria, was tabulated.

RESULTS

Strong consensus (≥ 80% of panelists rating their agreement as 6-7 on a scale from 1 to 7) was achieved for 68.6% (24/35) items. If less strict agreement criteria were applied (ratings 5-7 on the Likert-type scale), consensus was achieved for 88% (31/35) items.

CONCLUSIONS

We achieved consensus on a large majority of items pertaining to perioperative endocrine evaluation and management using a Delphi process. This provides an international real-world clinical perspective from an expert group and facilitates a framework for future guideline development. Some of the items for which consensus was not reached, including the assessment of immediate postoperative remission in acromegaly or Cushing's disease, represent areas where further research is needed.

摘要

目的

在成人和儿童中,经蝶窦手术(TSS)是大多数大型或功能性鞍区病变(除泌乳素瘤外)的主要治疗方法。内分泌评估和管理是围手术期护理的重要组成部分。然而,内分泌评估和管理的细节并未得到普遍认可。

方法

为了就接受 TSS 的成年人的内分泌评估和管理达成共识,采用了 Delphi 流程。垂体学会教育委员会制定了 35 项声明。邀请了 55 名垂体内分泌学家(均为垂体学会成员)参加两轮 Delphi 投票,对与围手术期内分泌评估和管理相关的声明表示同意程度,使用李克特量表进行评分。汇总了每位小组成员对每项内容的同意比例的匿名数据。根据预设标准列出达成共识的项目清单。

结果

对于 68.6%(24/35)的项目,强烈一致(≥80%的小组成员对 1 到 7 的量表评分 6-7)。如果应用较宽松的同意标准(李克特量表的评分 5-7),则有 88%(31/35)的项目达成共识。

结论

我们使用 Delphi 流程就大多数与围手术期内分泌评估和管理相关的项目达成了共识。这从专家小组提供了国际现实世界的临床视角,并为未来指南的制定提供了框架。一些未达成共识的项目,包括对肢端肥大症或库欣病患者术后即刻缓解的评估,代表了需要进一步研究的领域。